Precision for Medicine GmbH

DEF1103R.HRB88858B|Barbara-McClintock-Straße 6, 12489 BerlinGermany|2003

Profit€1.2M

Revenue€14.2M

Balance€8.8M

About

Precision for Medicine GmbH was founded in 2004 as Epiontis GmbH and has belonged to the Precision Medicine Group, USA since 28 September 2017. The company's purpose is to provide laboratory services to pharmaceutical and biotech clients, in particular laboratory-based analyses of patient samples in clinical trials; for this it operates an analysis laboratory for cellular and molecular biological characterization. At the Berlin site it built a biorepository for sample storage and a production facility to manufacture kits for sample collection and shipping. As of 31 December 2023 the company employed 91 staff; the subscribed capital amounts to EUR 300,000 and is fully paid in.

Business purpose (commercial register)

Die Nutzung molekularbiologischer Parameter, insbesondere auch der DNA-Methylierung und anderer epigenetischer Parameter zur Entwicklung präziser molekularbiologischer Verfahren zur Analyse von Zellen. Die Gesellschaft kann andere Unternehmen gleicher oder verwandter Art gründen, erwerben oder sich an ihnen beteiligen, Zweigniederlassungen im In- und Ausland errichten sowie alle Geschäfte betreiben, die geeignet sind, die Unternehmungen der Gesellschaft zu fördern.

ClassificationWZ 2025

N.74.91.1 - Verwertungsgesellschaften zur Wahrnehmung von Urheberrechten und verwandten Schutzrechten

Products

Labor Zellcharakterisierung Analysesystem Kits Biotechnologie Forschung

Opportunities & Risks

Netzinfrastruktur Service-Management Konzern Biotechnologie Kits Forschung

Inflation Personalmangel Währungsrisiken Auftragslage Finanzierungsrisiken

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 88858 (as of 25 August 2026)

Company Structure

Shareholders

Name	Type	City
Matthew DeZee	Geschäftsführer(in)	Arlington/Utah/USA
Karl Deonanan	Geschäftsführer(in)	Raleigh/ USA
Stacey Hanna	Geschäftsführer(in)	Bernardsville/USA
Krzysztof Mazurek	Geschäftsführer(in)	Warschau/Polen
Sven Olek	Geschäftsführer(in)	Berlin

Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 88858 (as of 25 August 2026)

Company History

Management

Date	Event Type	Event
24.06.2020	Company Name Change	Precision for Medicine GmbH
24.06.2020	Gesellschaftsvertrag amended	Gesellschaftsvertrag
20.07.2019	Business Address Change	Barbara-McClintock-Straße 6, 12489 Berlin

Date	Type	Change	Total Capital
07.11.2016	Capital Increase	+100.200 €	300.000 €
30.07.2015	Capital Increase	+133.200 €	199.800 €
31.07.2012	Capital Increase	+10.600 €	66.600 €

Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 88858 (as of 25 August 2026)

Financials

Key financial figures over time — Precision for Medicine GmbH
Year	Revenue	Profit	Balance	Employees
2024	€14,241,648	€1,218,591	€8,774,242	—
2023	€13,510,638	€509,302	€7,033,714	—
2022	Rohergebnis€9.8M²	€400,234	€8,067,337	—
2021	Rohergebnis€7.8M²	€659,255	€6,142,678	—
2020	—	-€52,626	€5,998,818	—
2019	—	€309,048	€6,246,782	—
2018	—	€463,987	€4,574,309	—
2017	—	€1,473,081	€3,849,058	—
2016	—	€1,462,323	€3,372,320	—
2015	—	€349,820	€2,219,802	—

¹ Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.

² Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

List of Shareholders

Articles of Association

Registration Application

Source: German Commercial Register (Handelsregister) Berlin (Charlottenburg) Local Court, HRB 88858 (as of 25 August 2026)

Similar Companies

fka GmbH

Aachen · Verwertungsgesellschaften zur Wahrnehmung von Urheberrechten und verwandten Schutzrechten

€19.3M

Sumitomo Rubber Europe GmbH

Hanau · Erbringung sonstiger Vermittlungs- und Vermarktungsdienstleistungen für Patente

€14.8M

TSI GmbH.

Aachen · Verwertungsgesellschaften zur Wahrnehmung von Urheberrechten und verwandten Schutzrechten

Annual Financial Statements

Annual Report 2024Published on 30 April 2026

Annual Report 2023Published on 22 April 2025

Annual Report 2022Published on 5 June 2024

Annual Report 2021Published on 30 March 2023

Annual Report 2020Published on 25 April 2022

Annual Report 2019Published on 5 March 2021

Annual Report 2018Published on 10 January 2020

Annual Report 2017Published on 24 January 2019

Annual Report 2016Published on 5 July 2017

Annual Report 2015Published on 9 September 2016

Annual Report 2014Published on 1 July 2015

Annual Report 2013Published on 10 September 2014

Annual Report 2012Published on 26 July 2013

Annual Report 2011Published on 20 July 2012

Annual Report 2010Published on 10 November 2011

Annual Report 2009Published on 10 August 2010

Annual Report 2008Published on 25 January 2010

Annual Report 2006Published on 7 May 2008

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Personnel Costs	€6,921,149	92.3%
Depreciation	€576,611	7.7%
Interest & Similar	€815	0.0%

Precision for Medicine GmbH

About

Business purpose (commercial register)

ClassificationWZ 2025

Products

Opportunities & Risks

Company Structure

Company History

Financials

Register Files

Similar Companies

Annual Financial Statements

Cost Distribution (2023)

Trends